- €2.11bn
- €1.52bn
- €534.50m
- 24
- 71
- 48
- 42
2020 December 31st | 2021 December 31st | R2022 December 31st | 2023 December 31st | |
---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | Interim Report | ARS |
Standards: | IFRS | IFRS | — | IFRS |
Status: | Final | Final | Final | Final |
Total Premiums Earned | ||||
Net Investment Income | ||||
Realized & Unrealized Gains / Losses | ||||
Other Revenue | ||||
Total Revenue | 1,266 | 1,775 | 994 | 535 |
Losses, Benefits, and Adjustments | ||||
Selling / General / Administrative Expenses | ||||
Depreciation and Amortization | ||||
Unusual Expense / Income | ||||
Other Operating Expenses | ||||
Total Operating Expenses | 1,497 | 2,934 | 302 | 332 |
Operating Profit | -231 | -1,159 | 693 | 203 |
Total Net Non Operating Interest Income / Expense | ||||
Other Net Non Operating Costs | ||||
Net Income Before Taxes | 154 | 247 | 681 | 210 |
Provision for Income Taxes | ||||
Net Income After Taxes | 117 | 196 | 543 | 161 |
Minority Interest | ||||
Net Income Before Extraordinary Items | ||||
Extraordinary Items | ||||
Net Income | 117 | 196 | 543 | 161 |
Adjustments to Net Income | ||||
Income Available to Common Shareholders Excluding Extraordinary Items | ||||
Income Available to Common Shareholders Including Extraordinary Items | ||||
Diluted Net Income | 117 | 196 | 543 | 161 |
Diluted Weighted Average Shares | ||||
Basic EPS Including Extraordinary Items | ||||
Diluted EPS Including Extraordinary Items | ||||
Diluted EPS Excluding Extraordinary Items | ||||
Normalised Income Before Taxes | ||||
Normalised Income After Taxes | ||||
Normalised Income Available to Common Shareholders | ||||
Diluted Normalised EPS | 0.233 | 0.391 | 1.08 | 0.339 |
Dividends per Share |